Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kendall Brown

Pediatric Gastroenterology Dallas, TX Medical Doctor

NPI 1407815228 CMS profile 335372

7777 Forest Ln, Suite B304, Dallas, TX 75230

Open in the dashboard

General payments

$2,740

122 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$15,012

4 holdings reported · through program year 2025

Through program year 2025, Kendall Brown of Dallas, TX is reported in the CMS Open Payments database as having received $2,740 across 122 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $15,012 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64 3
2024 General $418 18
2023 General $631 21
2022 General $338 19
2021 General $461 18
2020 General $348 20
2019 General $481 23
2024 Ownership $7,050 1
2023 Ownership $7,050 1
2022 Ownership $443 1
2021 Ownership $469 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kendall Brown
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Kendall Brown were reported at $64. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Kendall Brown Pediatric Gastroenterology median Middle half National median
2019 $481 $131 $41–$311 $163
2020 $348 $79 $23–$223 $114
2021 $461 $104 $32–$321 $132
2022 $338 $125 $37–$331 $149
2023 $631 $169 $55–$440 $160
2024 $418 $196 $73–$563 $164
2025 $64 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,529 61 payments
  2. Genzyme Corporation $243 11 payments
  3. Regeneron Healthcare Solutions, Inc. $197 8 payments
  4. Romark Laboratories, LC $144 12 payments
  5. Nestle HealthCare Nutrition Inc. $132 7 payments
  6. Alexion Pharmaceuticals, Inc. $85 3 payments
  7. Ipsen Biopharmaceuticals, Inc $65 3 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $57 2 payments
  9. Cumberland Pharmaceuticals, Inc. $49 3 payments
  10. Boehringer Ingelheim Pharmaceuticals, Inc. $43 2 payments
  11. Other $196 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,740 122 payments
Products named General payments · program years 2019–2025
  1. HUMIRA $793 35 payments
  2. CREON $341 16 payments
  3. DUPIXENT Immunology $243 11 payments
  4. DUPIXENT Inflammation And Immunology $197 8 payments
  5. RINVOQ $186 4 payments
  6. ALINIA Gastroenterology $144 12 payments
  7. ALINIA Gastroenterology $144 12 payments
  8. ALINIA Gastroenterology $144 12 payments
  9. SKYRIZI $91 5 payments
  10. ZENPEP $89 5 payments
  11. Other $436 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record